REVIVA PHARMACEUTICALS HOLDI (RVPH) Fundamental Analysis & Valuation

NASDAQ:RVPH • US76152G2093

Current stock price

0.7709 USD
-0.07 (-8.77%)
At close:
0.78 USD
+0.01 (+1.18%)
After Hours:

This RVPH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RVPH Profitability Analysis

1.1 Basic Checks

  • In the past year RVPH has reported negative net income.
  • RVPH had a negative operating cash flow in the past year.
  • RVPH had negative earnings in each of the past 5 years.
  • In the past 5 years RVPH always reported negative operating cash flow.
RVPH Yearly Net Income VS EBIT VS OCF VS FCFRVPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • RVPH has a worse Return On Assets (-124.75%) than 82.20% of its industry peers.
  • The Return On Equity of RVPH (-229.71%) is worse than 77.49% of its industry peers.
Industry RankSector Rank
ROA -124.75%
ROE -229.71%
ROIC N/A
ROA(3y)-161.13%
ROA(5y)-131.97%
ROE(3y)-1532.09%
ROE(5y)-992.53%
ROIC(3y)N/A
ROIC(5y)N/A
RVPH Yearly ROA, ROE, ROICRVPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • RVPH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RVPH Yearly Profit, Operating, Gross MarginsRVPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RVPH Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for RVPH has been increased compared to 1 year ago.
  • RVPH has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for RVPH has been reduced compared to a year ago.
RVPH Yearly Shares OutstandingRVPH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
RVPH Yearly Total Debt VS Total AssetsRVPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • RVPH has an Altman-Z score of -18.97. This is a bad value and indicates that RVPH is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of RVPH (-18.97) is worse than 84.82% of its industry peers.
  • A Debt/Equity ratio of 0.05 indicates that RVPH is not too dependend on debt financing.
  • RVPH's Debt to Equity ratio of 0.05 is in line compared to the rest of the industry. RVPH outperforms 51.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -18.97
ROIC/WACCN/A
WACCN/A
RVPH Yearly LT Debt VS Equity VS FCFRVPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that RVPH has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.08, RVPH is doing worse than 61.78% of the companies in the same industry.
  • RVPH has a Quick Ratio of 2.08. This indicates that RVPH is financially healthy and has no problem in meeting its short term obligations.
  • RVPH has a Quick ratio (2.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 2.08
RVPH Yearly Current Assets VS Current LiabilitesRVPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. RVPH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.51% over the past year.
EPS 1Y (TTM)44.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, RVPH will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.25% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y60.99%
EPS Next 2Y35.25%
EPS Next 3Y22.64%
EPS Next 5Y15.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RVPH Yearly Revenue VS EstimatesRVPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B
RVPH Yearly EPS VS EstimatesRVPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. RVPH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RVPH. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RVPH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVPH Price Earnings VS Forward Price EarningsRVPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVPH Per share dataRVPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • RVPH's earnings are expected to grow with 22.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.25%
EPS Next 3Y22.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RVPH Dividend Analysis

5.1 Amount

  • No dividends for RVPH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RVPH Fundamentals: All Metrics, Ratios and Statistics

REVIVA PHARMACEUTICALS HOLDI

NASDAQ:RVPH (4/10/2026, 8:00:01 PM)

After market: 0.78 +0.01 (+1.18%)

0.7709

-0.07 (-8.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-30
Earnings (Next)05-13
Inst Owners15.21%
Inst Owner Change0%
Ins Owners1.38%
Ins Owner Change0%
Market Cap9.88M
Revenue(TTM)N/A
Net Income(TTM)-19.86M
Analysts80
Price Target68 (8720.86%)
Short Float %N/A
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1144.46%
PT rev (3m)1059.42%
EPS NQ rev (1m)-1075%
EPS NQ rev (3m)-705.71%
EPS NY rev (1m)-1306.13%
EPS NY rev (3m)-930.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.14
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-18.2
EYN/A
EPS(NY)-3.11
Fwd EYN/A
FCF(TTM)-1.92
FCFYN/A
OCF(TTM)-1.92
OCFYN/A
SpS0
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -124.75%
ROE -229.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-161.13%
ROA(5y)-131.97%
ROE(3y)-1532.09%
ROE(5y)-992.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 2.08
Altman-Z -18.97
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.61%
EPS Next Y60.99%
EPS Next 2Y35.25%
EPS Next 3Y22.64%
EPS Next 5Y15.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.68%
OCF growth 3YN/A
OCF growth 5YN/A

REVIVA PHARMACEUTICALS HOLDI / RVPH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for REVIVA PHARMACEUTICALS HOLDI?

ChartMill assigns a fundamental rating of 2 / 10 to RVPH.


What is the valuation status for RVPH stock?

ChartMill assigns a valuation rating of 1 / 10 to REVIVA PHARMACEUTICALS HOLDI (RVPH). This can be considered as Overvalued.


Can you provide the profitability details for REVIVA PHARMACEUTICALS HOLDI?

REVIVA PHARMACEUTICALS HOLDI (RVPH) has a profitability rating of 0 / 10.


How financially healthy is REVIVA PHARMACEUTICALS HOLDI?

The financial health rating of REVIVA PHARMACEUTICALS HOLDI (RVPH) is 4 / 10.